ARCT Chart
- 52-Week Range: $13.04 - $58.25
- Market Capitalization: $477.39M
- Short Percentage: 0%
- Target Price: $56.09
- Shares Outstanding: 26.42M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
ARCT released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire | May 20th
- Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire | April 22nd
- Raymond James analyst doesn't expect Arcturus' COVID-19 vaccine to be authorized in the U.S.Market Watch | April 20th
- Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire | March 18th
- Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 28th
- Arcturus Therapeutics to Participate in the SVB Leerink 11th Annual Global Healthcare ConferenceBusiness Wire | February 8th
Company Info
Website: https://arcturusrx.com
Address: 10628 Science Center Drive, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 177
Address: 10628 Science Center Drive, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 177
$ARCT eyeing for a scalp
$ARCT I gave in! Bought more 100 shares
$ARCT just added more
$ARCT down hard at open
$ARCT gimme gimme
$ARCT buy SHARES
$ARCT Wish I shorted
$ARCT just fucking go already jeesh
$ARCT HODLing
and buying more when I can.
$ARCT LOL